Scientech Research’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Scientech Research's NVO Position: Q2 2026 in Review
Scientech Research sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 9,274 shares — an estimated $341K sold.
Scientech Research first reported a position in NVO in Q2 2024 and held it in 4 quarters. The position peaked at $1.09M in Q3 2025. 1,363 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Scientech Research reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
- Scientech Research sold 9,274 Novo Nordisk shares in Q2 2026, an estimated $341K.
- Scientech Research first reported a position in Novo Nordisk in Q2 2024 and held it in 4 quarters.
- Scientech Research's Novo Nordisk position peaked at $1.09M in Q3 2025.
- 1,363 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.